Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Payables (2016 - 2025)

Historic Payables for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $2.9 million.

  • Ekso Bionics Holdings' Payables fell 480.71% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 480.71%. This contributed to the annual value of $2.8 million for FY2024, which is 952.53% down from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' Payables is $2.9 million, which was down 480.71% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Payables peaked at $6.1 million during Q2 2023, and registered a low of $1.3 million during Q3 2021.
  • For the 5-year period, Ekso Bionics Holdings' Payables averaged around $3.3 million, with its median value being $3.1 million (2023).
  • Its Payables has fluctuated over the past 5 years, first plummeted by 6705.88% in 2021, then soared by 23509.17% in 2022.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Payables stood at $3.1 million in 2021, then skyrocketed by 75.76% to $5.5 million in 2022, then crashed by 43.29% to $3.1 million in 2023, then dropped by 9.53% to $2.8 million in 2024, then rose by 3.89% to $2.9 million in 2025.
  • Its Payables stands at $2.9 million for Q3 2025, versus $2.7 million for Q2 2025 and $3.2 million for Q1 2025.